Durvalumab and tremelimumab for hepatocellular carcinoma in patients listed for a liver transplant.

被引：0
|
作者：
Sohal, Davendra
Moreland, Katie
Quillin, Ralph
Lemon, Kristina
Rojan, Adam
Olowokure, Olugbenga Olanrele
Shah, Shimul
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS638
引用
收藏
页码：TPS638 / TPS638
页数：1
相关论文
共 50 条
  • [41] Management of liver transplant patients with recurrence of hepatocellular carcinoma
    Safak, Adem
    Karakaya, Emre
    Yildirim, Sedat
    Okyay, Ozan
    Boyvat, Fatih
    Tseveldorj, Nomingerel
    Boyacioglu, Sedat
    Haberal, Mehmet A.
    [J]. TRANSPLANTATION, 2024, 108 (09) : 648 - 648
  • [42] A New Liver Transplant Priority for Patients with Hepatocellular Carcinoma
    Ravaioli, Matteo
    Grazi, Gian Luca
    Vetrone, Gaetano
    Kimura, Takuya
    Zanello, Matteo
    Ercolani, Giorgio
    Cescon, Matteo
    Varotti, Giovanni
    Del Gaudio, Massimo
    Tuci, Francesco
    Cucchetti, Alessandro
    La Barba, Giuliano
    Vivarelli, Marco
    Lauro, Augusto
    Ramacciato, Giovanni
    Pinna, Antonio Daniele
    [J]. HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1742 - 1745
  • [43] Outcomes of Patients With Hepatocellular Carcinoma After Liver Transplant
    Moray, Gokhan
    Kirnap, Mahir
    Akdur, Aydincan
    Soy, Ebru
    Tezcaner, Tugan
    Boyvat, Fatih
    Ozdemir, Handan
    Haberal, Mehmet
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 : 30 - 32
  • [44] Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
    Duffy, Austin G.
    Ulahannan, Susanna V.
    Makorova-Rusher, Oxana
    Rahma, Osama
    Wedemeyer, Heiner
    Pratt, Drew
    Davis, Jeremy L.
    Hughes, Marybeth S.
    Heller, Theo
    ElGindi, Mei
    Uppala, Ashish
    Korangy, Firouzeh
    Kleiner, David E.
    Figg, William D.
    Venzon, David
    Steinberg, Seth M.
    Venkatesan, Aradhana M.
    Krishnasamy, Venkatesh
    Abi-Jaoudeh, Nadine
    Levy, Elliot
    Wood, Brad J.
    Greten, Tim F.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (03) : 545 - 551
  • [45] Liver Transplant and Hepatocellular Carcinoma
    Gish, Robert G.
    [J]. Clinical Advances in Hematology & Oncology, 2016, 14 (12) : 987 - 989
  • [46] Safety of prompt initiation of durvalumab or STRIDE (single tremelimumab regular interval durvalumab) regimen as hepatocellular carcinoma (HCC) treatment for patients with chronic active hepatitis B
    Shao, Yu-Yun
    Chen, Ching-Tso
    Wu, Tsung-Che
    Liu, Tsung-Hao
    Chuang, Chien-Huai
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    [J]. CANCER RESEARCH, 2024, 84 (07)
  • [47] Liver transplant versus liver resection in patients with multifocal hepatocellular carcinoma
    Kakish, Hanna
    Suraju, Mohammed O.
    Seth, Abhinav
    DiGioia, Olivia N.
    Pawar, Omkar
    Kwon, Yong K.
    Hemming, Alan W.
    Aziz, Hassan
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (07) : 1062 - 1066
  • [48] Combined immune checkpoint inhibition (ICI) with tremelimumab and durvalumab in patients with advanced hepatocellular carcinoma (HCC) or biliary tract carcinomas (BTC).
    Floudas, Charalampos S.
    Xie, Changqing
    Brar, Gagandeep
    Morelli, Maria Pia
    Fioravanti, Suzanne
    Walker, Melissa
    Mabry-Hrones, Donna
    Wood, Brad J.
    Levy, Elliot B.
    Krishnasamy, Venkatesh P.
    Greten, Tim F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [49] COST-EFFECTIVENESS OF TREMELIMUMAB PLUS DURVALUMAB FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
    Xiong, X.
    Guo, J. J.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S152 - S152
  • [50] Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
    Kelley, Robin Kate
    Sangro, Bruno
    Harris, William
    Ikeda, Masafumi
    Okusaka, Takuji
    Kang, Yoon-Koo
    Qin, Shukui
    Tai, David W-M
    Lim, Ho Yeong
    Yau, Thomas
    Yong, Wei-Peng
    Cheng, Ann-Lii
    Gasbarrini, Antonio
    Damian, Silvia
    Bruix, Jordi
    Borad, Mitesh
    Bendell, Johanna
    Kim, Tae-You
    Standifer, Nathan
    He, Philip
    Makowsky, Mallory
    Negro, Alejandra
    Kudo, Masatoshi
    Abou-Alfa, Ghassan K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (27) : 2991 - +
12345